Product Introduction:
Remylin contains Rasagiline Mesylate 1.5 mg, a selective monoamine oxidase-B (MAO-B) inhibitor that increases dopamine in the brain, helping to manage symptoms of Parkinson’s disease such as tremors and stiffness.
Uses:
-
Treatment of Parkinson’s disease
-
Management of motor symptoms such as rigidity, tremors, and bradykinesia
-
Can be used alone or with other Parkinson’s medications
Benefits:
-
Improves motor function and quality of life
-
Helps control disease progression
-
Reduces symptoms like tremors and muscle stiffness
Composition:
Each tablet contains:
-
Rasagiline Mesylate 1.5 mg
Side Effects:
May cause headache, dizziness, nausea, or insomnia. Report any severe side effects to your doctor promptly.
Safety Advice:
Take as prescribed by your healthcare provider. Avoid sudden discontinuation. Inform your doctor about other medications you are taking to avoid interactions. Store in a cool, dry place.
